Skip to search formSkip to main contentSkip to account menu

globotriaosyl lysosphingolipid

Known as: lyso-Gb3, Gb3 lysosphingolipid, lysoGb3 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2015
Highly Cited
2015
Background Fabry disease (FD), a lysosomal storage disorder caused by α-galactosidase A (GLA) gene variants, has a heterogeneous… 
Highly Cited
2013
Highly Cited
2013
BACKGROUND Biochemical markers that accurately reflect the severity and progression of disease in patients with Fabry disease and… 
Highly Cited
2012
Highly Cited
2012
ABSTRACT Staphylococci cause bovine mastitis, with Staphylococcus aureus being responsible for the majority of the mastitis-based… 
Highly Cited
2012
Highly Cited
2012
Introduction Enzyme replacement therapy (ERT) with alpha-Galactosidase A (aGal A) may cause antibody (AB) formation against aGal… 
Highly Cited
2010
Highly Cited
2009
Highly Cited
2009
Verotoxin binding to its receptor, globotriaosyl ceramide(Gb(3)) mediates the glomerular pathology of hemolytic uremic syndrome… 
Review
2007
Review
2007
Enveloped viruses infect host cells by fusion of viral and target membranes. This fusion event is triggered by specific… 
Highly Cited
1994
Highly Cited
1994
The glycosphingolipid globotriaosyl ceramide (CD77) and other globo- series glycolipids containing terminal galactose (Gal)alpha…